Clarus CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
CLAR
Clarus CORPClarus Corporation's Schedule 13D filing reveals amendments to pledge agreements for over 1.6 million shares of common stock, impacting Warren B. Kanders and Kanders GMP Holdings, LLC.
NASDAQ
CLAR
Clarus CORPSCHEDULE 13D/A: Clarus Corporation Board Approves Executive Chairman Kanders to Increase Stake to 32.9%
Clarus Corporation's Board of Directors has approved Executive Chairman Warren B. Kanders' request to increase his beneficial ownership in the company to approximately 32.9% of outstanding shares, subject to specific conditions.